ID
24570
Beschreibung
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive
Stichworte
Versionen (1)
- 06.08.17 06.08.17 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
6. August 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
Beschreibung
If "yes" to COPD exacerbation, record following items.
Alias
- UMLS CUI-1
- C0740304
Beschreibung
date of onset of COPD exacerbation
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0574845
- UMLS CUI [1,2]
- C0740304
Beschreibung
outcome of COPD exacerbation
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0085565
- UMLS CUI [1,2]
- C0740304
Beschreibung
date of resolution or death
Datentyp
date
Alias
- UMLS CUI [1]
- C2985858
- UMLS CUI [2]
- C1148348
Beschreibung
severity of COPD excerbation
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0439793
- UMLS CUI [1,2]
- C0740304
Beschreibung
Subjects who experience more than one moderate exacerbation requiring antibiotic and/or oral corticosteroid treatment during the treatment period and/or experience a severe exacerbation requiring hospitalisation during the course of the study must be withdrawn.
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0740304
Ähnliche Modelle
COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
C0740304 (UMLS CUI [1,2])
C0740304 (UMLS CUI [1,2])
C1148348 (UMLS CUI [2])
C0740304 (UMLS CUI [1,2])
C0740304 (UMLS CUI [1,2])